Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
357 Mechanisms of LGALS3BP-driven resistance to TIL therapy
5 affiliations
- 1Massachusetts General Hospital, Boston, MA, USA
- 21Massachusetts General Hospital, Boston, MA, USA
- 3Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- 4Mass General Brigham Cancer Institute, Boston, Massachusetts, USA
- 5Medical University of South Carolina, Charleston, SC, USA
Related
- Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
- Shining a Light on the Mechanisms of Drug Resistance to Anti-PD-1 Therapy in Non-small Cell Lung Cancer.
- Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective
- Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translation.
- Antimicrobial Therapy, Disinfection, Resistance Mechanisms, and Microbiota Interactions in Nontuberculous Mycobacteria: Current Evidence and Emerging Perspectives.
BibTeX
@article{lawless2026mechanisms,
title = {{357 Mechanisms of LGALS3BP-driven resistance to TIL therapy}},
author = {Aleigha Lawless and Tatyana Sharova and Moshe Sade-Feldman and Hongyan Xie and Jacy Fang and Sonia Cohen and Genevieve M Boland and Sarah E San Vicente and Russell W Jenkins},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0357},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0357},
note = {CC BY},
}
RIS
TY - JOUR
TI - 357 Mechanisms of LGALS3BP-driven resistance to TIL therapy
AU - Aleigha Lawless
AU - Tatyana Sharova
AU - Moshe Sade-Feldman
AU - Hongyan Xie
AU - Jacy Fang
AU - Sonia Cohen
AU - Genevieve M Boland
AU - Sarah E San Vicente
AU - Russell W Jenkins
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0357
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0357
SN - 2051-1426
ER -